SAN RAFAEL, Calif., Aug. 10, 2026 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today

BioMarin stock rises on Q2 sales beat and raises 2026 outlook, highlighting strong Voxzogo growth, A

BioMarin Pharmaceutical Inc. (BMRN) Q2 2026 Earnings Call Transcript

While the top- and bottom-line numbers for BioMarin (BMRN) give a sense of how the business performe

BioMarin Pharmaceutical NASDAQ: BMRN reported second-quarter 2026 revenue of nearly $1 billion, up 2

BioMarin Pharmaceutical (BMRN) came out with quarterly earnings of $1.2 per share, beating the Zacks

Second Quarter 2026 Total Revenues Increased 20% Year-over-year to $990 million Stronger Growth Expe

Amundi trimmed its position in shares of BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) by 4.6% during

SAN RAFAEL, Calif., July 30, 2026 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today

BioMarin (BMRN) doesn't possess the right combination of the two key ingredients for a likely earnin

ReNU syndrome was discovered in 2024 and there are no medicines approved for the condition Collabora

Bank of New York Mellon Corp decreased its position in shares of BioMarin Pharmaceutical Inc. (NASDA

BioMarin: Commercial Infrastructure Is The Hidden Growth Asset

D.A. Davidson and CO. boosted its holdings in shares of BioMarin Pharmaceutical Inc. (NASDAQ: BMRN)

Citigroup analyst Eric Joseph maintains BioMarin Pharmaceutical (NASDAQ:BMRN) with a Buy and rais

BioMarin's FDA filing for full Voxzogo approval in achondroplasia has been accepted, with a regulato

The sNDA submission was supported by substantial long-term safety and efficacy data from three ongoi

Application based on long-term safety and efficacy data from three ongoing studies, including adult

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investi

Data from an investigator-led study showed treatment with VOXZOGO resulted in sustained improvements

BioMarin (BMRN) reported earnings 30 days ago. What's next for the stock?

BMRN's shares rise after Voxzogo hits the main goal in a late-stage hypochondroplasia study, support

BridgeBio stock rises after Phase 3 trial shows its drug helped children with achondroplasia grow fa

CAMP4 signs ASO collaboration with GSK, securing $17.5 million upfront as analysts reaffirm Outperfo

'Secretary Kennedy Adds Duchenne Muscular Dystrophy, Metachromatic Leukodystrophy To Newborn Screeni

Companies Reporting Before The Bell • Keurig Dr Pepper (NASDAQ:KDP) is projected to report quarterl

Hedge fund Elliott Management revealed a Q2 portfolio reshuffle, adding new positions tied to major

CAMP4 Therapeutics raises $75 million in IPO, advances RNA therapies for rare diseases, and partners

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings

Companies Reporting Before The Bell • GSK (NYSE:GSK) is expected to report quarterly earnings at $1

Companies Reporting Before The Bell • Immunogen (NASDAQ:IMGN) is estimated to report quarterly loss

Companies Reporting Before The Bell • Teck Resources (NYSE:TECK) is expected to report quarterly ea

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly ear

On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended holding Biomarin Pharmaceutica

Upgrades

Companies Reporting Before The Bell • LG Display Co (NYSE:LPL) is projected to report quarterly los

  Companies Reporting Before The Bell • Fresh Del Monte Produce (NYSE:FDP) is likely to report qua

  On Tuesday, 951 companies hit new 52-week lows.

  During Monday's trading, 1214 companies set new 52-week lows.

  Companies Reporting Before The Bell • Deutsche Bank (NYSE:DB) is projected to report earnings fo

  Companies Reporting Before The Bell • Sapiens Intl Corp (NASDAQ:SPNS) is likely to report earnin